Etid klinik pou Twoub san nan Alabama
5 etid pou Twoub san ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University Of Alabama, Birmingham
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
Ap rekriteFaz 3
Laj 18 a 71 · Tout sèks · Mizajou Sep 23, 2026 · NCT07504458BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 15, 2025 · NCT06472089Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT06034275Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 89 Years · Tout sèks · Mizajou Nov 9, 2022 · NCT03848962Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.